Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-10-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement regarding the revision of the company's Articles of Association (公司章程). It details specific amendments to the company's bylaws related to share repurchase and capital structure. The document is relatively short (1506 characters) and serves as a formal notice of these changes, including the need for shareholder approval at an upcoming extraordinary general meeting. There are no financial statements, audit opinions, or detailed financial data presented. This is not a full report but an announcement of governance changes related to company bylaws. Therefore, the most appropriate classification is 'Governance Information' (CGR).
2018-10-30 Chinese
2018年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 Third Quarter Report" of 华邦生命健康股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial indicators and changes compared to previous periods. The document includes management statements ensuring the accuracy of the report, detailed financial tables, and explanations of significant changes in financial data. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-10-30 Chinese
第七届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the seventh board of directors' fourth meeting of Huabang Life Health Co., Ltd. It includes multiple agenda items such as approval of the 2018 third quarter report, election of non-independent directors, appointment of general manager, acquisition of company shares, changes in accounting policies, and amendments to internal control and company charter. The document also references other announcements and reports published elsewhere but itself is a formal record of board meeting decisions. It does not contain the full financial report or detailed financial data but rather the board's resolutions and voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board meeting resolutions.
2018-10-30 Chinese
关于公司总经理辞职暨聘任新总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's general manager and the appointment of a new general manager. It includes details about the outgoing and incoming managers, their qualifications, and compliance with relevant regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting vote result. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2018-10-30 Chinese
关于补选第七届董事会非独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a non-independent director to the company's board, including details about the candidate's qualifications and compliance with relevant laws and regulations. It references the company's board structure and the process for filling a board vacancy. There is no financial data, earnings information, or report publication mentioned. The content clearly pertains to changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on this topic, confirming it is not a full report or announcement of a report publication.
2018-10-30 Chinese
募集资金使用管理办法（2018年10月）
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金使用管理办法' which translates to 'Measures for the Management and Use of Raised Funds' by 华邦生命健康股份有限公司. It details the rules, procedures, and regulations regarding the management, storage, usage, supervision, and changes in the use of funds raised by the company through securities issuance. The content includes regulatory references, internal controls, approval processes, and disclosure requirements related to fundraising activities. It is a detailed policy or procedural document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but focuses on governance and compliance related to capital raising and fund usage. Therefore, it fits best under Capital/Financing Update (CAP) as it provides comprehensive updates and rules on the company's fundraising and capital management activities.
2018-10-30 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.